Given the observed increase in proteins found in the PI3K/AKT signaling pathway in activin (+) regions of the tumor, we next explored the potential role for activin and the PI3K pathway in transwell migration assays performed on the ACVR2A-expressing HCT116+chr2 cell line. The gene discussed is ACVR2A; the disease is neoplasm.